Brief: Marksans Pharma Announces FDA Approval For Acetaminophen And Ibuprofen Tablets
12/07/2023 06:42
July 12 (Reuters) - Marksans Pharma Ltd MARK.NS :
* MARKSANS ANNOUNCES FDA APPROVAL OF OTC EQUIVALENT OF ADVIL
DUAL
ACTION TABLETS
* ANDA APPROVAL FOR ACETAMINOPHEN AND IBUPROFEN TABLETS
Source text for Eikon: ID:nBSE5w4qBL
Further company coverage: MARK.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Marksans Pharma
See all newsIndia's Marksans Pharma jumps to over 18-month high after more than doubling quarterly profit
Brief: Marksans Pharma Ltd To Acquire 100% Of Netherlands-Based Qliniq B.V
India's Marksans Pharma jumps to 10-month high after Q4 profit rise
Brief: Marksans Pharma March-Quarter Consol Net Profit 1.48 Billion Rupees
Brief: Marksans Pharma Ltd Receives USFDA Approval For Benzonatate Capsules USP, 100 Mg & 200 Mg